BioWorld

April 10, 2002

View Archived Issues

Roche Paying Isotechnika Up To $215M For Transplantation Drug

Hoffmann-La Roche Inc. agreed to spend upward of $215 million in a global partnership with Isotechnika Inc. to develop a transplantation drug with blockbuster potential. (BioWorld Today) Read More

AEterna Seeks Acquisitions In Cancer Following C$57M Financing

Read More

Subterranean Naked Mole-Rats’ All-Purpose Incisors Neuronally Sensed In Huge Neocortex Area

Read More

Hyseq Raises $15M Privately To Develop Proprietary Drugs

Read More

Other News To Note

Read More

ImClone Presents Preclinical Data Of Erbitux In Combination Study

Read More